U.S. Markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
480.17-1.82 (-0.38%)
At close: 4:00PM EDT

Thermo Fisher Scientific Inc.

168 Third Avenue
Waltham, MA 02451
United States
781 622 1000
http://www.thermofisher.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees75,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Marc N. CasperCEO, Pres & Chairman6.27M31.86M1968
Mr. Stephen WilliamsonSr. VP & CFO1.74MN/A1967
Mr. Mark P. StevensonExec. VP & COO2.78MN/A1963
Mr. Syed A. JafrySr. VP & Pres of Regions1.26M2.26M1964
Mr. Michel LagardeExec. VP2.28MN/A1975
Mr. Peter E. HornstraVP & Chief Accounting OfficerN/AN/A1960
Mr. Ryan J. SnyderSr. VP & Chief Information OfficerN/AN/AN/A
Mr. Kenneth J. ApicernoVP of Investor RelationsN/AN/AN/A
Mr. Michael A. Boxer Esq.Sr. VP & Gen. CounselN/AN/A1962
Ms. Sandy PoundVP & Chief Communications OfficerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrödinger, Inc. to expand structure-based drug discovery to novel targets using Cryo-EM; and an agreement with Daiichi Sankyo to co-develop a companion diagnostic. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.

Corporate Governance

Thermo Fisher Scientific Inc.’s ISS Governance QualityScore as of October 6, 2020 is 6. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 5; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.